At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP).
One of the highlights of the CES event last week was the Nvidia Corp. keynote delivered by Chief Executive Jensen Huang.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback